TSX:CURAPharmaceuticals
Curaleaf Holdings (TSX:CURA) Is Down 5.8% After Strong International Gains and Wider Net Loss—Has the Bull Case Changed?
Curaleaf Holdings, Inc. recently reported third quarter 2025 earnings, posting revenue of US$320.24 million and a net loss of US$57.03 million, with strong international revenue growth of 12% sequentially and 56% year-over-year.
The company also completed the acquisition of its minority partner in Curaleaf International, launched a medically certified liquid inhalation device in the UK and Germany, and secured a US$100 million revolving line of credit to support further expansion.
We'll...